PLoS Medicine, ISSN 1549-1277, 2014, Volume 11, Issue 5, p. e1001638
Background: Yellow fever is a vector-borne disease affecting humans and non-human primates in tropical areas of Africa and South America. While eradication is...
ANTIBODIES | MORTALITY | IMMUNIZATION | NIGERIA | MEDICINE, GENERAL & INTERNAL | INFECTIONS | PERSISTENCE | REEMERGENCE | RISK | EPIDEMIC | MAP | Geography | Mass Vaccination | Africa - epidemiology | Yellow Fever - prevention & control | Humans | Yellow Fever - mortality | Cost of Illness | Seroepidemiologic Studies | Yellow Fever - transmission | Cause of Death | Regression Analysis | Bayes Theorem | Yellow Fever - epidemiology | Disease Outbreaks - prevention & control | Prevention | Epidemics | Vaccination | Africa | Management | Social aspects | Yellow fever | Medical research | Immunization | Sensitivity analysis | Disease | Infections | Vaccines | Alliances | Estimates | Fever | Tropical diseases | Methods
ANTIBODIES | MORTALITY | IMMUNIZATION | NIGERIA | MEDICINE, GENERAL & INTERNAL | INFECTIONS | PERSISTENCE | REEMERGENCE | RISK | EPIDEMIC | MAP | Geography | Mass Vaccination | Africa - epidemiology | Yellow Fever - prevention & control | Humans | Yellow Fever - mortality | Cost of Illness | Seroepidemiologic Studies | Yellow Fever - transmission | Cause of Death | Regression Analysis | Bayes Theorem | Yellow Fever - epidemiology | Disease Outbreaks - prevention & control | Prevention | Epidemics | Vaccination | Africa | Management | Social aspects | Yellow fever | Medical research | Immunization | Sensitivity analysis | Disease | Infections | Vaccines | Alliances | Estimates | Fever | Tropical diseases | Methods
Journal Article
Trends in Parasitology, ISSN 1471-4922, 2006, Volume 22, Issue 12, pp. 552 - 557
Leishmaniasis, a neglected tropical disease, has strong but complex links with poverty. The burden of leishmaniasis falls disproportionately on the poorest...
SOUTHERN SUDAN | IMPACT | RISK-FACTORS | NEGLECTED TROPICAL DISEASES | KALA-AZAR | ANTHROPONOTIC CUTANEOUS LEISHMANIASIS | VISCERAL LEISHMANIASIS | BANGLADESHI COMMUNITY | BRAZIL | INDIA | PARASITOLOGY | Poverty | Humans | Antiprotozoal Agents - economics | Male | Leishmaniasis, Cutaneous - drug therapy | Socioeconomic Factors | Leishmaniasis, Visceral - drug therapy | Endemic Diseases | Animals | Leishmaniasis, Cutaneous - parasitology | Leishmaniasis, Cutaneous - economics | Leishmaniasis, Cutaneous - epidemiology | Female | Developing Countries | Leishmaniasis, Visceral - parasitology | Antiprotozoal Agents - therapeutic use | Leishmania - growth & development | Leishmaniasis, Visceral - economics | Leishmaniasis, Visceral - epidemiology | Health aspects | Leishmaniasis
SOUTHERN SUDAN | IMPACT | RISK-FACTORS | NEGLECTED TROPICAL DISEASES | KALA-AZAR | ANTHROPONOTIC CUTANEOUS LEISHMANIASIS | VISCERAL LEISHMANIASIS | BANGLADESHI COMMUNITY | BRAZIL | INDIA | PARASITOLOGY | Poverty | Humans | Antiprotozoal Agents - economics | Male | Leishmaniasis, Cutaneous - drug therapy | Socioeconomic Factors | Leishmaniasis, Visceral - drug therapy | Endemic Diseases | Animals | Leishmaniasis, Cutaneous - parasitology | Leishmaniasis, Cutaneous - economics | Leishmaniasis, Cutaneous - epidemiology | Female | Developing Countries | Leishmaniasis, Visceral - parasitology | Antiprotozoal Agents - therapeutic use | Leishmania - growth & development | Leishmaniasis, Visceral - economics | Leishmaniasis, Visceral - epidemiology | Health aspects | Leishmaniasis
Journal Article
American Journal of Tropical Medicine and Hygiene, ISSN 0002-9637, 09/2013, Volume 89, Issue 3, pp. 434 - 444
Current regulations stipulate a yellow fever (YF) booster every 10 years. We conducted a systematic review of the protective efficacy and duration of immunity...
17D VACCINE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | NEUTRALIZING ANTIBODIES | CLINICAL-TRIAL | IMMUNOGLOBULIN-M | IMMUNOFLUORESCENCE ASSAY | IGG ANTIBODIES | ANTIBODY-RESPONSE | ARTHROPOD-BORNE VIRUSES | TROPICAL MEDICINE | HIV-INFECTED PATIENTS | IMMUNIZATION PRACTICES
17D VACCINE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | NEUTRALIZING ANTIBODIES | CLINICAL-TRIAL | IMMUNOGLOBULIN-M | IMMUNOFLUORESCENCE ASSAY | IGG ANTIBODIES | ANTIBODY-RESPONSE | ARTHROPOD-BORNE VIRUSES | TROPICAL MEDICINE | HIV-INFECTED PATIENTS | IMMUNIZATION PRACTICES
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue 49, pp. 5798 - 5805
Highlights • Reviewed, re-analyzed literature pertaining to YEL-AVD among the elderly. • Lack of strong evidence for contraindication of yellow fever vaccine....
Allergy and Immunology | Adverse event | Yellow fever vaccine | Viscerotropic disease | Elderly | Yellow fever | MEDICINE, RESEARCH & EXPERIMENTAL | SAFETY | DEATH | IMMUNOLOGY | FAILURE | ADVANCED AGE | BRAZIL | CHILDREN | IMMUNOGENICITY | SERIOUS ADVERSE EVENTS | 17D | SPAIN | Yellow Fever Vaccine - adverse effects | Vaccination - adverse effects | Age Factors | Drug-Related Side Effects and Adverse Reactions | Humans | Risk Factors | Complications and side effects | Aged | Vaccines | Public health | Studies | Travel | Immunization | Older people | Classification | Fatalities | Age | Data bases
Allergy and Immunology | Adverse event | Yellow fever vaccine | Viscerotropic disease | Elderly | Yellow fever | MEDICINE, RESEARCH & EXPERIMENTAL | SAFETY | DEATH | IMMUNOLOGY | FAILURE | ADVANCED AGE | BRAZIL | CHILDREN | IMMUNOGENICITY | SERIOUS ADVERSE EVENTS | 17D | SPAIN | Yellow Fever Vaccine - adverse effects | Vaccination - adverse effects | Age Factors | Drug-Related Side Effects and Adverse Reactions | Humans | Risk Factors | Complications and side effects | Aged | Vaccines | Public health | Studies | Travel | Immunization | Older people | Classification | Fatalities | Age | Data bases
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 11/2017, Volume 17, Issue 11, pp. 1209 - 1217
Substantial outbreaks of yellow fever in Angola and Brazil in the past 2 years, combined with global shortages in vaccine stockpiles, highlight a pressing need...
SYSTEMATIC ANALYSIS | IMMUNIZATION COVERAGE | INFECTIOUS DISEASES | ANGOLA | Yellow Fever - prevention & control | Yellow Fever Vaccine - administration & dosage | Global Health | Humans | Vaccination | Yellow Fever - epidemiology | Retrospective Studies | Analysis | Target marketing | Vector-borne diseases | Epidemics | Innovations | Infections | Vaccines | Estimates | Disease control | Fever | Prevention | Charities | Population | Yellow fever
SYSTEMATIC ANALYSIS | IMMUNIZATION COVERAGE | INFECTIOUS DISEASES | ANGOLA | Yellow Fever - prevention & control | Yellow Fever Vaccine - administration & dosage | Global Health | Humans | Vaccination | Yellow Fever - epidemiology | Retrospective Studies | Analysis | Target marketing | Vector-borne diseases | Epidemics | Innovations | Infections | Vaccines | Estimates | Disease control | Fever | Prevention | Charities | Population | Yellow fever
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 12/2018, Volume 18, Issue 1, pp. 707 - 14
BackgroundThe emergence of different viral infections during the last decades like dengue, West Nile, SARS, chikungunya, MERS-CoV, Ebola, Zika and Yellow Fever...
Viruses | Diagnostics | Sample type | Emerging diseases | INFECTIOUS DISEASES | WEST-NILE-VIRUS | SARS-ASSOCIATED CORONAVIRUS | EBOLA HEMORRHAGIC-FEVER | CHIKUNGUNYA VIRUS | SQUIRRELS SCIURUS-NIGER | REVERSE-TRANSCRIPTASE PCR | NEW-YORK-CITY | RESPIRATORY SYNDROME-CORONAVIRUS | DENGUE VIRUS | ZIKA VIRUS | Urine | Emerging communicable diseases | Medical research | Salivary glands | Salivary diagnostics | Research | Virus diseases | Analysis | Medicine, Experimental | Diagnosis | Saliva | Health aspects | secretions | Health care | Vector-borne diseases | Epidemics | Laboratories | Dengue | Diagnostic tests | Viral diseases | Outbreaks | Infections | Zika virus | Patients | Fever | Ebola virus | Respiratory diseases | Sampling methods | Diagnostic systems | Sampling | Viral infections | Yellow fever
Viruses | Diagnostics | Sample type | Emerging diseases | INFECTIOUS DISEASES | WEST-NILE-VIRUS | SARS-ASSOCIATED CORONAVIRUS | EBOLA HEMORRHAGIC-FEVER | CHIKUNGUNYA VIRUS | SQUIRRELS SCIURUS-NIGER | REVERSE-TRANSCRIPTASE PCR | NEW-YORK-CITY | RESPIRATORY SYNDROME-CORONAVIRUS | DENGUE VIRUS | ZIKA VIRUS | Urine | Emerging communicable diseases | Medical research | Salivary glands | Salivary diagnostics | Research | Virus diseases | Analysis | Medicine, Experimental | Diagnosis | Saliva | Health aspects | secretions | Health care | Vector-borne diseases | Epidemics | Laboratories | Dengue | Diagnostic tests | Viral diseases | Outbreaks | Infections | Zika virus | Patients | Fever | Ebola virus | Respiratory diseases | Sampling methods | Diagnostic systems | Sampling | Viral infections | Yellow fever
Journal Article
Vaccine, ISSN 0264-410X, 03/2019, Volume 37, Issue 11, pp. 1384 - 1388
Recent yellow fever (YF) outbreaks have highlighted the increasing global risk of urban spread of the disease. In context of recurrent vaccine shortages,...
Visualization | Shiny | Vaccination | Africa | Outbreak response | Yellow fever | MEDICINE, RESEARCH & EXPERIMENTAL | DISEASE | IMMUNOLOGY | Epidemics | Communicable diseases | World health | Urban sprawl | Internet software | Epidemiology | Vector-borne diseases | Medical research | Immunization | Disease | Shortages | Collating | Health risks | Outbreaks | Vaccines | Estimates | Immunity | Fever | Demographics | Applications programs | Software | Age | Public health | Age groups | Life Sciences | Santé publique et épidémiologie
Visualization | Shiny | Vaccination | Africa | Outbreak response | Yellow fever | MEDICINE, RESEARCH & EXPERIMENTAL | DISEASE | IMMUNOLOGY | Epidemics | Communicable diseases | World health | Urban sprawl | Internet software | Epidemiology | Vector-borne diseases | Medical research | Immunization | Disease | Shortages | Collating | Health risks | Outbreaks | Vaccines | Estimates | Immunity | Fever | Demographics | Applications programs | Software | Age | Public health | Age groups | Life Sciences | Santé publique et épidémiologie
Journal Article
8.
Full Text
Atypical Clinical Presentations of Acute Phase Chikungunya Virus Infection in Older Adults
Journal of the American Geriatrics Society, ISSN 0002-8614, 11/2017, Volume 65, Issue 11, pp. 2510 - 2515
Objectives We aimed to determine whether the presentation of Chikungunya virus (CHIKV) infection differs between older and younger adults with regard to...
older adults | clinical forms | Chikungunya virus infection | MORTALITY | REUNION ISLAND | RISK | FRAILTY | GERIATRICS & GERONTOLOGY | PATHOGENESIS | DISEASES | GERONTOLOGY | OUTBREAK | EPIDEMIOLOGY | LIFE | Chikungunya Fever - diagnosis | Age Distribution | Fever of Unknown Origin - virology | Age Factors | Cross-Sectional Studies | Humans | Middle Aged | Risk Factors | Male | Reverse Transcriptase Polymerase Chain Reaction | Arthralgia - virology | Chikungunya Fever - epidemiology | Aged, 80 and over | Female | Aged | Retrospective Studies | Chikungunya virus - isolation & purification | Virus diseases | DNA polymerases | Public health | Polymerase chain reaction | RNA-directed DNA polymerase | Pain | Older people | Fever | Life Sciences | Human health and pathology | Infectious diseases
older adults | clinical forms | Chikungunya virus infection | MORTALITY | REUNION ISLAND | RISK | FRAILTY | GERIATRICS & GERONTOLOGY | PATHOGENESIS | DISEASES | GERONTOLOGY | OUTBREAK | EPIDEMIOLOGY | LIFE | Chikungunya Fever - diagnosis | Age Distribution | Fever of Unknown Origin - virology | Age Factors | Cross-Sectional Studies | Humans | Middle Aged | Risk Factors | Male | Reverse Transcriptase Polymerase Chain Reaction | Arthralgia - virology | Chikungunya Fever - epidemiology | Aged, 80 and over | Female | Aged | Retrospective Studies | Chikungunya virus - isolation & purification | Virus diseases | DNA polymerases | Public health | Polymerase chain reaction | RNA-directed DNA polymerase | Pain | Older people | Fever | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 12/2016, Volume 214, Issue 12, p. S510
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 12/2016, Volume 214, Issue suppl 5, pp. S441 - S445
Chikungunya virus (CHIKV) emerged in the Americas in late 2013 to cause substantial acute and chronic morbidity. About 1.1 million cases of chikungunya were...
Chikungunya | Americas | Arbovirus | Epidemiology | Emerging disease | MORTALITY | INFECTIOUS DISEASES | RISK-FACTORS | MICROBIOLOGY | IMMUNOLOGY | SEROPREVALENCE | chikungunya | arbovirus | epidemiology | ISLAND | emerging disease | VIRUS-INFECTIONS | Chikungunya virus - genetics | Risk Assessment | Communicable Diseases, Emerging - embryology | Humans | Communicable Diseases, Emerging - epidemiology | Chikungunya Fever - prevention & control | Mosquito Vectors - virology | Chikungunya Fever - virology | Chikungunya virus - immunology | Americas - epidemiology | Aedes - virology | Animals | Climate Change | Communicable Diseases, Emerging - prevention & control | Chikungunya Fever - complications | Chikungunya Fever - epidemiology | Chikungunya virus - physiology | Communicable Diseases, Emerging - virology | Evolution, Molecular
Chikungunya | Americas | Arbovirus | Epidemiology | Emerging disease | MORTALITY | INFECTIOUS DISEASES | RISK-FACTORS | MICROBIOLOGY | IMMUNOLOGY | SEROPREVALENCE | chikungunya | arbovirus | epidemiology | ISLAND | emerging disease | VIRUS-INFECTIONS | Chikungunya virus - genetics | Risk Assessment | Communicable Diseases, Emerging - embryology | Humans | Communicable Diseases, Emerging - epidemiology | Chikungunya Fever - prevention & control | Mosquito Vectors - virology | Chikungunya Fever - virology | Chikungunya virus - immunology | Americas - epidemiology | Aedes - virology | Animals | Climate Change | Communicable Diseases, Emerging - prevention & control | Chikungunya Fever - complications | Chikungunya Fever - epidemiology | Chikungunya virus - physiology | Communicable Diseases, Emerging - virology | Evolution, Molecular
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 03/2018, Volume 12, Issue 3, p. e0006284
Background Yellow fever virus (YFV) is a vector- borne flavivirus endemic to Africa and Latin America. Ninety per cent of the global burden occurs in Africa...
DENGUE | MALARIA TRANSMISSION | AEDES-AEGYPTI DIPTERA | VIRUS | TEMPERATURE | CULICIDAE | RISK | MODEL | GLOBAL DISTRIBUTION | BRAZIL | PARASITOLOGY | TROPICAL MEDICINE | Aedes - physiology | Climate | Temperature | Yellow fever virus - physiology | Yellow fever virus - isolation & purification | Humans | Mosquito Vectors - virology | Yellow Fever - transmission | Democratic Republic of the Congo - epidemiology | Mosquito Vectors - physiology | Aedes - virology | Angola - epidemiology | Animals | Virus Replication | Yellow Fever - virology | Disease Outbreaks | Yellow Fever - epidemiology | Environment | Seasons | Brazil - epidemiology | Mosquitoes | Disease transmission | Influence | Research | Health aspects | Yellow fever | Endemic species | Funding | Seasonality | Transmission | Outbreaks | Viruses | Aquatic insects | Epidemiology | Tropical diseases | Seasonal variations | Life cycle | Demographics | Regression models | Annual | Temperature effects | Life cycle engineering | Temporal variations | Viral replication | Geographical distribution | Environmental assessment | Vector-borne diseases | Temperature dependence | Immunization | Statistical analysis | Rainfall | Regression analysis | Fever | Climate change | Infectious diseases | Replication | Models | Interactions | Life cycles
DENGUE | MALARIA TRANSMISSION | AEDES-AEGYPTI DIPTERA | VIRUS | TEMPERATURE | CULICIDAE | RISK | MODEL | GLOBAL DISTRIBUTION | BRAZIL | PARASITOLOGY | TROPICAL MEDICINE | Aedes - physiology | Climate | Temperature | Yellow fever virus - physiology | Yellow fever virus - isolation & purification | Humans | Mosquito Vectors - virology | Yellow Fever - transmission | Democratic Republic of the Congo - epidemiology | Mosquito Vectors - physiology | Aedes - virology | Angola - epidemiology | Animals | Virus Replication | Yellow Fever - virology | Disease Outbreaks | Yellow Fever - epidemiology | Environment | Seasons | Brazil - epidemiology | Mosquitoes | Disease transmission | Influence | Research | Health aspects | Yellow fever | Endemic species | Funding | Seasonality | Transmission | Outbreaks | Viruses | Aquatic insects | Epidemiology | Tropical diseases | Seasonal variations | Life cycle | Demographics | Regression models | Annual | Temperature effects | Life cycle engineering | Temporal variations | Viral replication | Geographical distribution | Environmental assessment | Vector-borne diseases | Temperature dependence | Immunization | Statistical analysis | Rainfall | Regression analysis | Fever | Climate change | Infectious diseases | Replication | Models | Interactions | Life cycles
Journal Article
BMC Public Health, ISSN 1471-2458, 08/2018, Volume 18, Issue 1, pp. 1011 - 10
Background: Yellow fever (YF) is a viral hemorrhagic fever, endemic in the tropical forests of Africa and Central and South America. The disease is transmitted...
Risk assessment | Ethiopia | Flaviviruses | Yellow fever | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | RISK-ASSESSMENT | EPIDEMIOLOGY | Zika Virus - immunology | Public Health | Yellow Fever - prevention & control | Enzyme-Linked Immunosorbent Assay | West Nile virus - immunology | Humans | Middle Aged | Child, Preschool | Male | Neutralization Tests | Seroepidemiologic Studies | Yellow fever virus - immunology | Antibodies, Viral - blood | Ethiopia - epidemiology | Young Adult | Dengue Virus - immunology | Adolescent | Epidemics - prevention & control | Yellow Fever - epidemiology | Adult | Female | Yellow Fever Vaccine | Aged | Child | Prevention | Surveys | Control | Disease transmission | Analysis | Patient outcomes | Prevalence studies (Epidemiology) | Vector-borne diseases | Epidemics | Forests | Disease | Dengue fever | Dengue | Viruses | Zika virus | Epidemiology | Fever | Tropical diseases | Disease prevention | Mosquitoes | Surveillance | Fatalities | Public health
Risk assessment | Ethiopia | Flaviviruses | Yellow fever | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | RISK-ASSESSMENT | EPIDEMIOLOGY | Zika Virus - immunology | Public Health | Yellow Fever - prevention & control | Enzyme-Linked Immunosorbent Assay | West Nile virus - immunology | Humans | Middle Aged | Child, Preschool | Male | Neutralization Tests | Seroepidemiologic Studies | Yellow fever virus - immunology | Antibodies, Viral - blood | Ethiopia - epidemiology | Young Adult | Dengue Virus - immunology | Adolescent | Epidemics - prevention & control | Yellow Fever - epidemiology | Adult | Female | Yellow Fever Vaccine | Aged | Child | Prevention | Surveys | Control | Disease transmission | Analysis | Patient outcomes | Prevalence studies (Epidemiology) | Vector-borne diseases | Epidemics | Forests | Disease | Dengue fever | Dengue | Viruses | Zika virus | Epidemiology | Fever | Tropical diseases | Disease prevention | Mosquitoes | Surveillance | Fatalities | Public health
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 12/2016, Volume 214, Issue suppl 5, pp. S510 - S513
Discovered in 1953, chikungunya virus (CHIKV) circulated in Africa and Southeast Asia, with periodic outbreaks, for many years. Highly efficient transmission...
Aedes albopictus | Chikungunya virus | Chikungunya | Alphavirus | Aedes aegypti | CHIKV | Virus-like particles | virus-like particles | INFECTIOUS DISEASES | MICROBIOLOGY | chikungunya virus | alphavirus | IMMUNOLOGY | EPIDEMIC | chikungunya | Americas | Chikungunya Fever - diagnosis | World Health Organization | Chikungunya virus - genetics | United States | Humans | Chikungunya Fever - virology | Chikungunya Fever - transmission | Aedes - virology | Animals | Disease Outbreaks | Viral Vaccines | Chikungunya Fever - therapy | National Institute of Allergy and Infectious Diseases (U.S.) | Mutation | Chikungunya virus - pathogenicity | Practice Guidelines as Topic
Aedes albopictus | Chikungunya virus | Chikungunya | Alphavirus | Aedes aegypti | CHIKV | Virus-like particles | virus-like particles | INFECTIOUS DISEASES | MICROBIOLOGY | chikungunya virus | alphavirus | IMMUNOLOGY | EPIDEMIC | chikungunya | Americas | Chikungunya Fever - diagnosis | World Health Organization | Chikungunya virus - genetics | United States | Humans | Chikungunya Fever - virology | Chikungunya Fever - transmission | Aedes - virology | Animals | Disease Outbreaks | Viral Vaccines | Chikungunya Fever - therapy | National Institute of Allergy and Infectious Diseases (U.S.) | Mutation | Chikungunya virus - pathogenicity | Practice Guidelines as Topic
Journal Article
The Lancet Global Health, ISSN 2214-109X, 03/2018, Volume 6, Issue 3, pp. e270 - e278
Yellow fever cases are under-reported and the exact distribution of the disease is unknown. An effective vaccine is available but more information is needed...
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Journal Article